Tear Osmolarity Clinical Utility in Dry Eye Disease
- Conditions
- Dry Eye
- Interventions
- Other: SalineOther: Tear supplementOther: Tear supplement 2Dietary Supplement: Omega 3 nutrition supplementDevice: Eye bag
- Registration Number
- NCT02417116
- Lead Sponsor
- Aston University
- Brief Summary
Millions of people suffer from dry eye disease, causing symptoms such as redness, burning, feeling of sand or grit in the eye and light sensitivity. Dry eye disease occurs when your eyes do not produce enough tears or produce poor quality tears. This can happen for a number of reasons, including aging, hormonal changes in women and side effects of diseases or medications.
It is now possible to objectively measure the degree of dry eye disease by collecting a tiny sample of tears from the corner of the eye and then measuring the amount of salt in the tears (termed osmolarity). We aim to establish the overall levels of raised and normal tear osmolarity in people presenting to the eye clinic with complaints of dry eye, and relate this to other factors such as symptoms, topical and nutritional medication and dry eye treatment.
- Detailed Description
This study will investigate the efficacy of two treatment non-pharmaceutical therapies (tear drop alone, tear drop combined with omega 3 nutritional supplement and warm compresses) for dry eye reporting patients against a control (saline) over a 3 month period. A relatively new clinical measure (osmolarity) will be performed alongside traditional tear film volume, tear film stability, gland integrity and ocular surface damage measures to determine how this influences symptomatic complaints.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Dry Eye Symptoms SPEED >8
- Unable to participate in 90 days therapy
- Allergic to therapy
- On medication known to affect ocular surface / tear film
- Had ocular trauma, infection or surgery
- Diagnosed with a medical condition known to affect ocular surface / tear film
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Saline Minims Saline (Preservative Free) lubricant eye drops - daily for 90 days Hypromellose - standard treatment Tear supplement Tear Supplement: Hypromellose 0.3% eye drops - daily for 90 days Combination treatment Eye bag Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days; Combination treatment Omega 3 nutrition supplement Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days; Combination treatment Tear supplement 2 Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;
- Primary Outcome Measures
Name Time Method Osmolarity change 3 months Salt balance in tears measured with the Tearlab
- Secondary Outcome Measures
Name Time Method Tear break-up time change 3 months Tear stability following a blink
Corneal staining change 3 months Fluorescein dye applied to the ocular surface and observed with blue light and a yellow filter to observe staining fluorescence
Tear Meniscus Height 3 months Height of tear meniscus along the lower lid margin observed through a slit-lamp microscope
SPEED Questionnaire change 3 months Dry eye symptomology questionnaire
Meibomian gland change 3 months Grading of meibomian glands using Oxford scale
Trial Locations
- Locations (2)
Black & Lizars Optometrists
🇬🇧Glasgow, United Kingdom
Robert Frith Opticians
🇬🇧Twickenham, Middlesex, United Kingdom